# Limbic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/limbic

- Industry: Software
- Headquarters: London, UK
- Website: www.limbic.ai
- Total disclosed funding: $14M
- Latest round: Series A (Mar 5, 2024)
- Investors on record: 4

## About

Based in London, UK, and founded in 2017 by co-founders Ross Harper and Sebastiaan de Vries, Limbic Limited offers end-to-end software backed by artificial intelligence that works to quantify mental health-related issues to ensure better psychology therapy and tackle disability worldwide. The firm’s partners include NHS Calderdale, DR Julian, King’s College London, UCL Partners, etc. In March 2024, Limbic raised USD 14 million in Series A funding led by investor Khosla Ventures, with participation from other investors Gaingels and Illusian Group.

Limbic provides mobile therapy assistants who provide cognitive-behavioral therapy (CBT) to therapy patients while keeping them engaged. The software collects patient information and tracks their progress using conversational AI, which records an individual's key patterns to assist caregivers in reviewing each individual, providing personalized recommendations of coping strategies, and sustaining their change via a ready-made relapse prevention toolkit. The software developed by the company is multilingual and works with Improving Access to Psychological Therapies (IAPT) systems. Patients can use the software to manage their emotions, keep a mood journal, and receive 24/7 support and personalized advice.

The company will use the March 2024 funding to expand its clinical mental health AI services to the US market.

## Funding rounds

- Series A, Mar 5, 2024, $14M — Khosla Ventures, Gaingels, Illusian Group
- Seed, Feb 1, 2020 — 7percent Ventures

## Investors

- 7percent Ventures (https://capitalatlas.ai/funds/7percent-ventures) — Seed
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series A
- Illusian Group — Series A